Tarsus Pharmaceuticals (TARS) Q2 2025 Earnings

1MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.94
-0.83
-0.71
-0.6

Details

Expected EPS
-0.729871
Actual EPS
-0.64
Surprise EPS
0.09
Surprise Percent
+12.31%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -0.64 per share for Q2 2025.

0 Comments

Share your thoughts